Out of curiosity, has IMGN stopped all research against this rare cancer form.

 

I ask because I saw an old NWBO Expert theater presentation in which their DCVax-L was given to a Merkle Cell patient under compassionate use and the patient is doing well after many years.  I'm wondering if IMGN's drug could compliment the DCVax-L.

 

We should get a release about ASCO from the company after all presentations have been made, and I believe it should come before the open on Monday.  Hopefully it will continue our upward trend to new highs.

 

Gary